Form 4: Baker Hughes Director Sells Over 18,000 Shares

Baker Hughes Director William G Beattie sold 18,023 shares of Class A Common Stock for approximately $1.03 million.

Summary

• William G Beattie, a Director of Baker Hughes Co (BKR), reported a sale of Class A Common Stock.
• The transaction involved the disposition of 18,023 shares.
• The shares were sold on February 3, 2026, at a weighted average price of $57.29 per share.
• The sales occurred in multiple transactions with prices ranging from $57.29 to $57.305.
• The total value of the shares sold is approximately $1,032,090.67.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.
• Following this transaction, William G Beattie's indirect beneficial ownership through Cannonbury Investments Limited is 0 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a pre-scheduled transaction under a 10b5-1 plan, which typically indicates a routine financial management decision rather than a reaction to new company-specific information.

Negatives

• A director's sale of shares, even if pre-planned, reduces their direct equity stake in the company.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding Baker Hughes' future performance or outlook.

Industry Context

StockSavvy.ai notes that insider transactions, such as this director's sale, are common occurrences. When executed under a Rule 10b5-1(c) plan, these sales are typically pre-scheduled and do not necessarily reflect a change in the insider's view of the company's immediate prospects or performance. Such transactions are part of routine personal financial management for executives and directors.

Related Party Transactions

• The shares were indirectly owned and sold by Cannonbury Investments Limited, which is related to Director William G Beattie.

Stakeholder Impact

• Shareholders: Minimal direct impact from a single, pre-planned director sale, as it does not signal a change in company fundamentals.

Key Dates

Recommendation

The reported transaction is a routine, pre-scheduled insider sale by a director under a 10b5-1 plan. It does not provide new fundamental information about Baker Hughes' operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Investors should continue to evaluate the company based on its core business performance and broader market conditions.

Keywords

Baker Hughes, BKR, Form 4, Insider Sale, Director Transaction, Equity Sale, 10b5-1 Plan